Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SPECIALLÆGE BJØRN ASSER HANSEN. ORTOPÆDKIRURGISK KLINIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   23.0% 22.5% 19.8% 16.4% 14.9% 21.8% 20.4% 20.4%   Credit score (0-100)   5 5 6 12 14 4 5 4   Credit rating   B B B BB BB B B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   -12.5 -43.8 -60.2 -60.0 -89.3 -69.5 0.0 0.0   EBITDA   -12.5 -43.8 -60.2 -60.0 -89.3 -69.5 0.0 0.0   EBIT   -12.5 -43.8 -60.2 -60.0 -89.3 -69.5 0.0 0.0   Pre-tax profit (PTP)   -1.0 -31.5 -47.7 -47.5 -76.8 -69.5 0.0 0.0   Net earnings   -1.0 -31.3 -47.7 -47.5 -77.7 -69.5 0.0 0.0   Pre-tax profit without non-rec. items   -24.0 -31.3 -47.7 -47.5 -76.8 -69.5 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   201 170 122 75.0 44.8 53.5 -146 -146   Interest-bearing liabilities   0.0 0.0 0.0 0.0 59.7 0.0 146 146   Balance sheet total (assets)   214 238 174 219 257 53.5 0.0 0.0   Net Debt   -6.0 -17.5 -12.4 -47.7 -197 -53.5 146 146     See the entire balance sheet 1000.0 Volume  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   -12.5 -43.8 -60.2 -60.0 -89.3 -69.5 0.0 0.0   Gross profit growth   0.0% -250.5% -37.4% 0.4% -48.8% 22.2% 0.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   214 238 174 219 257 54 0 0   Balance sheet change%   0.0% 11.2% -27.2% 26.1% 17.3% -79.2% -100.0% 0.0%   Added value   -12.5 -43.8 -60.2 -60.0 -89.3 -69.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 -2.0 -3.0 -4.0 -5.0 -5.0 0.0 0.0   1000.0 Profitability  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -5.8% -19.3% -29.2% -30.6% -32.3% -44.8% 0.0% 0.0%   ROI %   -6.2% -23.6% -41.1% -60.8% -85.6% -88.0% 0.0% 0.0%   ROE %   -0.5% -16.8% -32.6% -48.1% -129.8% -141.4% 0.0% 0.0%   1000.0 Solidity  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Equity ratio %   94.0% 71.4% 70.5% 34.3% 17.4% 100.0% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   47.7% 40.0% 20.6% 79.4% 220.8% 77.0% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 133.3% 0.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Quick Ratio   16.6 3.5 3.4 1.5 1.2 0.0 0.0 0.0   Current Ratio   16.6 3.5 3.4 1.5 1.2 0.0 0.0 0.0   Cash and cash equivalent   6.0 17.5 12.4 47.7 256.8 53.5 0.0 0.0   1000.0 Capital use efficiency  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   201.5 170.2 122.5 75.0 44.8 53.5 -73.2 -73.2   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0